Related Experiment Video
Updated: Mar 13, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
FTSJ1-mediated IL1RN mRNA instability promotes inflammation-driven hepatocellular carcinoma
Shuya Jiang1, Dongyang Ding1, Yunxi Zu1
1The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Shanghai, China.
Background:
The role of 2'-O-methyltransferases in hepatocellular carcinoma (HCC) progression, particularly concerning inflammation, remains unclear. This study investigated their prognostic significance, identified key prognostic target FTSJ1, and elucidated its inflammatory-related biological functions and molecular mechanisms.
Methods:
Transcriptomic data from The Cancer Genome Atlas-Liver Hepatocellular Carcinoma (TCGA-LIHC) were integrated to data of subtype HCC patients via consensus clustering based on 2'-O-methyltransferase expression. Single-gene survival analysis linked FTSJ1, FTSJ2, FTSJ3, and FBL to prognosis. A four-gene risk model was built. Multivariate COX regression identified independent risk factors. FTSJ1 expression and prognostic value were validated clinically using quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC). Functional roles were assessed in vitro [Cell Counting Kit-8 (CCK-8), Transwell, apoptosis/cell cycle assays] and in vivo (xenograft models). Mechanisms were explored via RNA sequencing (RNA-seq), gene set enrichment analysis (GSEA), and inflammatory cytokine detection.
Results:
Consensus clustering defined three subtypes. Subtype 1 (high 2'-O-methyltransferase expression) showed the worst prognosis. FTSJ1/2/3 and FBL correlated significantly with survival. The four-gene risk model predicted survival across cohorts [The Cancer Genome Atlas (TCGA)/Gene Expression Omnibus (GEO) datasets (GSE54236/GSE144269)]. FTSJ1 was an independent risk factor [multivariate Cox, hazard ratio (HR) =2.268, P=0.01] and significantly elevated in HCC tissues. Functionally, FTSJ1 knockdown inhibited proliferation and migration; induced G0/G1 arrest; promoted apoptosis in vitro; and suppressed tumor growth in vivo. Mechanistically, FTSJ1 drove HCC progression by reducing RNA stability of the key anti-inflammatory gene interleukin 1 receptor antagonist (IL1RN), leading to downregulated tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and enhanced pro-inflammatory signaling.
Conclusions:
High 2'-O-methyltransferase abundance predicts poor HCC prognosis. FTSJ1 is a novel independent prognostic biomarker and oncogenic factor that promotes HCC progression by dysregulating the inflammatory response pathway, highlighting its translational potential in inflammation-driven HCC.
Related Concept Videos
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Regulation of the Unfolded Protein Response
Leaky Scanning
RNA Splicing

